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ARF1 and ARF4 regulate recycling endosomal 
morphology and retrograde transport from 
endosomes to the Golgi apparatus
Waka Nakaia,*, Yumika Kondoa,*, Akina Saitoha, Tomoki Naitoa, Kazuhisa Nakayamaa, 
and Hye-Won Shina,b
aGraduate School of Pharmaceutical Sciences and bCareer-Path Promotion Unit for Young Life Scientists, Kyoto 
University, Sakyo-ku, Kyoto 606-8501, Japan
ABSTRACT Small GTPases of the ADP-ribosylation factor (ARF) family, except for ARF6, 
mainly localize to the Golgi apparatus, where they trigger formation of coated carrier vesi-
cles. We recently showed that class I ARFs (ARF1 and ARF3) localize to recycling endosomes, 
as well as to the Golgi, and are redundantly required for recycling of endocytosed transferrin. 
On the other hand, the roles of class II ARFs (ARF4 and ARF5) are not yet fully understood, 
and the complementary or overlapping functions of class I and class II ARFs have been poor-
ly characterized. In this study, we find that simultaneous depletion of ARF1 and ARF4 induces 
extensive tubulation of recycling endosomes. Moreover, the depletion of ARF1 and ARF4 
inhibits retrograde transport of TGN38 and mannose-6-phosphate receptor from early/recy-
cling endosomes to the trans-Golgi network (TGN) but does not affect the endocytic/recy-
cling pathway of transferrin receptor or inhibit retrograde transport of CD4-furin from late 
endosomes to the TGN. These observations indicate that the ARF1+ARF4 and ARF1+ARF3 
pairs are both required for integrity of recycling endosomes but are involved in distinct trans-
port pathways: the former pair regulates retrograde transport from endosomes to the TGN, 
whereas the latter is required for the transferrin recycling pathway from endosomes to the 
plasma membrane.
INTRODUCTION
Membrane traffic between subcellular compartments is mediated 
by vesicular and tubular intermediates. Members of the ADP-ribosy-
lation factor (ARF) family of small GTPases are key regulators of 
transport carrier formation; ARFs trigger budding of coated carrier 
vesicles by recruiting coat protein complexes and regulating phos-
pholipid metabolism (D’Souza-Schorey and Chavrier, 2006). As with 
other GTPases, binding of GTP to ARFs induces a conformational 
change that allows them to interact with a variety of effector pro-
teins, including coat proteins such as the COPI complex, clathrin 
adaptor protein complexes, and GGAs, as well as lipid-modifying 
enzymes, such as phospholipase D, phosphatidylinositol 4-kinase, 
and phosphatidylinositol 4-phosphate 5-kinase (Shin and Nakayama, 
2004). Conversion of GDP-bound, inactive forms of ARFs to GTP-
bound, active forms is catalyzed by guanine-nucleotide exchange 
factors (GEFs). In mammals, there are several subfamilies of ARF-
GEFs, including the brefeldin A–sensitive Gea/GBF1 and BIG1/
BIG2 subfamilies, which localize mainly to the cis-Golgi and trans-
Golgi network (TGN), respectively (Jackson and Casanova, 2000; 
Shin and Nakayama, 2004).
ARFs can be divided into three classes based on amino acid se-
quence similarity: class I includes ARF1 and ARF3 (humans lack 
ARF2); class II comprises ARF4 and ARF5; and the sole member of 
class III is ARF6 (Tsuchiya et al., 1991). Class I and II ARFs localize 
primarily to the Golgi apparatus and function in the Golgi and com-
partments along the secretory pathway, whereas ARF6 functions 
mainly at the plasma membrane (D’Souza-Schorey and Chavrier, 
2006). Class I and class II ARFs share 96 and 90% of their amino ac-
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In this study, we unexpectedly found that simultaneous deple-
tion of ARF1 and ARF4 induces drastic tubulation of recycling endo-
somes and inhibits retrograde transport of TGN38 and mannose 
6-phosphate receptor (MPR) from those compartments to the TGN 
but does not affect the Tfn recycling pathway from those compart-
ments to the plasma membrane.
RESULTS
Combinatorial depletion of class I and class II ARFs
To understand potentially redundant functions of ARFs in membrane 
traffic (Volpicelli-Daley et al., 2005), we used small interfering RNAs 
(siRNAs) to systematically deplete HeLa cells of Golgi-localizing 
ARFs, either singly or in pairwise combinations, and then examined 
the resulting morphological alterations of the Golgi apparatus and 
endosomes, as revealed by staining with antibodies against GM130 
(for the cis-Golgi), golgin-245 (for the TGN), and transferrin receptor 
(TfnR; for endosomes). Efficient and specific depletion of each ARF 
was confirmed by immunoblot analysis (Supplemental Figure S1). 
No single knockdown of any ARF induced significant morphological 
changes in these compartments (data not shown). As we previously 
reported, simultaneous knockdown of ARF1 and ARF3 induces tu-
bulation of TfnR-positive endosomes (Figure 1B′′; Kondo et al., 
2012). In addition, we observed extensive tubulation of TfnR-posi-
tive endosomes in cells depleted of both ARF1 and ARF4 (Figure 
1D′′, enlarged images). This observation was unexpected because a 
previous study (Ben-Tekaya et al., 2010) showed that double knock-
down of ARF1+4 induces formation of tubular structures from the 
ERGIC (also see Supplemental Figure S2, staining for ERGIC-53). 
Furthermore, the Golgi structure revealed by staining for GM130 
and golgin-245 exhibited a restricted juxtanuclear localization in 
cells depleted of ARF1+4 (Figure 1, D and D′), in contrast to the re-
ticular and perinuclear Golgi morphology observed in the control 
cells (Figure 1, A and A′). No other combinatorial knockdown 
(ARF1+5, ARF3+4, or ARF3+5) significantly changed the structure 
classes share 81% amino acid identity. Because of their high similar-
ity, pairs of class I and II ARFs often play redundant roles (Volpicelli-
Daley et al., 2005), but the specific and/or complementary functions 
of the ARF pairs are largely unknown.
ARF1 and ARF6 are the most thoroughly characterized ARFs. 
ARF1 is localized mainly to the Golgi apparatus, where it is respon-
sible for formation of COPI-coated vesicles, whereas ARF6 is local-
ized mainly to the plasma membrane and regulates the endocytic 
and recycling pathways and cytoskeletal remodeling (D’Souza-
Schorey and Chavrier, 2006). On the other hand, ARF4 and ARF5 are 
localized to the endoplasmic reticulum (ER)–Golgi intermediate 
compartment (ERGIC) as well as to the Golgi (Chun et al., 2008) and 
are involved in transport between the ERGIC and the Golgi (Volpi-
celli-Daley et al., 2005). ARF1 and ARF4 are also localized to the 
ERGIC as well as the Golgi (Chun et al., 2008; Ben-Tekaya et al., 
2010), are activated by GBF1 (Szul et al., 2007), and play a role in 
tubule formation from the ERGIC (Ben-Tekaya et al., 2010).
In addition to their conventional roles at the Golgi, class I and 
class II ARFs have a variety of functions. We and others showed that 
BIG2, which activates ARF1 and ARF3, localizes to recycling endo-
somes, as well as to the TGN, and is required for maintaining the 
structural integrity of recycling endosomes (Shin et al., 2004; Shen 
et al., 2006; Ishizaki et al., 2008). We also showed that ARF1 and 
ARF3 are localized to recycling endosomes and that simultaneous 
depletion of these ARFs induces tubulation of these compartments 
and inhibits the transferrin (Tfn) recycling pathway but not the endo-
cytic pathway (Kondo et al., 2012). On the other hand, ARF4 is as-
sociated with the TGN and plays a role in transport of ciliary cargoes 
(Mazelova et al., 2009), and ARF5 mediates integrin internalization 
(Moravec et al., 2012). A recent study described a functional ARF 
cascade in which ARF4 and ARF5 activated by GBF1 in turn pro-
mote recruitment of BIG1 and BIG2 to the TGN after recruitment of 
AP-1 (Lowery et al., 2013). Thus it is likely that the cellular functions 
of ARFs are not confined to their principal locations.
FIGURE 1: Combinatorial depletion of class I and class II ARFs. HeLa cells were treated with siRNAs against LacZ 
(control; A), ARF1 and ARF3 (B), ARF4 and ARF5 (C), ARF1 and ARF4 (D), ARF1 and ARF5 (E), ARF3 and ARF4 (F), or 
ARF3 and ARF5 (G). The cells were stained for GM130 (A–G), golgin-245 (A′–G′), or TfnR (A′′–G′′). The boxed areas in 
D′′ are enlarged. Bar, 20 μm.
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 ARF4, suggesting that the mechanism un-
derlying the tubulation induced by ARF1+4 
depletion is distinct from that of ARF1+3 
depletion (see later discussion). Subse-
quently we focused on the roles of ARF1 
and ARF4 in membrane trafficking via endo-
somes because ARF4 functions on endo-
somes have not been previously described.
Depletion of ARF1+4 induces 
tubulation of Rab11- and Rab4-positive 
endosomes
We next examined the distribution of Rab11, 
which localizes to recycling endosomes, in 
cells depleted of ARF1, ARF4, or ARF1+4 
(Figure 3). Rab11- and TfnR-positive struc-
tures were extensively tubulated in cells de-
pleted of ARF1+4 but not in cells depleted 
of ARF1 or ARF4 alone (Figure 3, A–A′′′ and 
B–B′′′, and enlarged images). The alterna-
tive set of siRNA pools against ARF1 and 
ARF4 (siARF1′ and siARF4′) also induced tu-
bulation of TfnR- and Rab11-positive com-
partments (Supplemental Figure S3C). The 
tubular structures positive for TfnR and 
Rab11 were extensively colocalized (Supple-
mental Figure S3C), indicating that these 
structures were generated from recycling 
endosomal compartments.
We next asked whether other endosomal 
Rab proteins localize to the tubular struc-
tures induced by depletion of ARF1+4. In 
addition to Rab11, Rab4, which localizes to 
early/recycling endosomes, was also ob-
served on the tubular structures (Figure 4). 
By contrast, early endosomal Rab5 was not 
associated with the tubules. Consistent with 
this, punctate structures positive for EEA1, 
an early endosomal marker, were not changed by depletion of 
ARF1+4 (Supplemental Figure S3C). Thus simultaneous depletion 
of ARF1 and ARF4 induces tubules from Rab11- and Rab4-positive 
recycling endosomes. We previously showed that simultaneous de-
pletion of ARF1 and ARF3 also induces tubulation of Rab11- and 
Rab4-positive endosomes (Kondo et al., 2012). As noted earlier, 
however, the tubules derived from recycling endosomes observed 
in cells depleted of ARF1+3 and of ARF1+4 are likely to be gener-
ated by distinct mechanisms.
Depletion of ARF1+4 does not inhibit endocytosis or 
recycling of Tfn
We next examined the dynamics of the Tfn/TfnR-positive tubular 
structures by time-lapse imaging. When cells stably expressing 
TfnR-EGFP were incubated at 37°C for 30 min with Alexa Fluor 
555–conjugated Tfn, endocytosed Tfn was extensively colocalized 
with TfnR-EGFP in both control and ARF1+4–depleted cells 
(Figure 5A and Supplemental Videos S1 and S2), indicating that 
ARF1+4 depletion does not affect endocytosis of Tfn or its accessi-
bility to TfnR-positive structures, despite the drastic morphological 
changes. In control cells, a number of vesicular and short tubular 
structures positive for both Tfn and TfnR could be observed moving 
around the cytoplasm (Figure 5A, left, and Supplemental Video S1). 
On the other hand, in the double-knockdown cells, endocytosed 
of the Golgi or TfnR-positive endosomes, although depletion of 
ARF4+5 resulted in a slightly more compact Golgi shape (Figure 1, 
C and C′).
To confirm that the endosomal tubulation observed in ARF1+4 
double-knockdown cells resulted from specific ARF depletion rather 
than an off-target effect, we performed two sets of experiments. 
When we treated HeLa cells with another set of siRNA pools target-
ing ARF1 and ARF4 (siARF1′ and siARF4′, respectively), we also 
observed tubulation of TfnR-positive compartments (Supplemental 
Figure S3C). In rescue experiments, exogenous expression of 
C-terminally enhanced green fluorescent protein (EGFP)–tagged 
ARF1 or ARF4 in double-knockdown cells restored the tubular TfnR-
positive structures to normal punctate ones (Figure 2, A, b and c, 
and B). By contrast, the tubular phenotype was not rescued by ex-
ogenous expression of EGFP, ARF3-EGFP, or ARF5-EGFP (Figure 2, 
A, a, d, and e, and B). These observations demonstrate that the 
tubulation of TfnR-positive endosomes observed in cells simultane-
ously treated with siRNAs against ARF1 and ARF4 results from spe-
cific depletion of these ARF proteins. Moreover, these findings 
indicate that ARF1 and ARF4 play redundant roles in maintaining 
the integrity of TfnR-positive endosomes. Although ARF1 and ARF3 
also are indispensable for the integrity of recycling endosomes 
(Volpicelli-Daley et al., 2005; Kondo et al., 2012), ARF3 cannot res-
cue the tubulation induced by simultaneous depletion of ARF1 and 
FIGURE 2: Alteration of endosomal structures by depletion of ARF1 and ARF4 is restored by 
exogenous expression of either ARF1 or ARF4. (A) HeLa cells treated with siRNAs against ARF1 
and ARF4 were transfected with an expression plasmid for EGFP, ARF1-EGFP, ARF4-EGFP, 
ARF3-EGFP, or ARF5-EGFP. Cells were then stained for TfnR. Each image represents data from 
two independent experiments. Bar, 20 μm. (B) The number of cells in which TfnR-containing 
structures were tubulated (white), partially tubulated (gray), or not tubulated (black) in A was 
counted and normalized against the total number of counted cells (>20 transfected cells were 
counted).
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consistent with a previous report showing 
that knockdown of ARF1 and ARF4 by 
shRNAs did not inhibit endocytosis or recy-
cling of Tfn (Volpicelli-Daley et al., 2005). 
Taken together, these findings indicate that 
although ARF1 and ARF4 participate redun-
dantly in maintaining TfnR-positive endo-
somal morphology, they are dispensable 
for Tfn endocytosis and recycling. This con-
trasts with observations in ARF1+3 knock-
down cells, in which the double knockdown 
not only induces tubulation of TfnR- and 
Rab11-positive endosomes but also inhibits 
recycling of endocytosed Tfn (Kondo et al., 
2012; also see Supplemental Figure S4).
Depletion of ARF1+4 inhibits 
retrograde transport of TGN38/46 
from endosomes to the TGN
Although the Golgi morphology was some-
what altered in cells depleted of ARF1+4, 
GM130 and golgin-245 were still associ-
ated with Golgi membranes (Figure 1), 
indicating that the Golgi apparatus itself 
remains intact under these conditions. In 
striking contrast, levels of TGN46 in the 
Golgi region were dramatically reduced in 
the double-knockdown cells (Figure 3, 
D–D′′′). In addition, the double knockdown 
of ARF1+4, but neither single knockdown, 
redistributed cation-independent MPR 
(CI-MPR) from the perinuclear Golgi region 
to tubular structures at the cell periphery 
(Figure 3, C–C′′′). Similarly, we observed 
reduced levels of TGN46 at the TGN and 
redistribution of CI-MPR in cells treated 
with another set of siRNA pools against 
ARF1 and ARF4 (Supplemental Figure S3C). 
After arriving at the plasma membrane, CI-MPR and TGN46 are 
delivered to the TGN via early/recycling endosomes (Maxfield and 
McGraw, 2004). Therefore ARF1 and ARF4 may play redundant 
roles in trafficking of these transmembrane proteins from endo-
somes to the TGN. In addition, levels of the AP-1 γ-subunit were 
significantly reduced in the TGN and peripheral endosomes in 
cells depleted of ARF1+4 (Figure 3, E–E′′′), but the total cellular 
level of this protein was not altered (Supplemental Figure S5), sug-
gesting that ARF1 and ARF4 participate in recruitment of the AP-1 
complex to TGN and endosomal membranes (see Discussion).
Given the drastic reduction in TGN46 at the TGN (Figure 3D′′′), 
retrograde transport of TGN46 to the TGN might be inhibited in the 
double-knockdown cells. We therefore examined the retrograde 
transport of rat TGN38, an orthologue of human TGN46, which tra-
verses through early/recycling endosomes en route to the TGN 
(Ghosh et al., 1998; Mallet and Maxfield, 1999; Maxfield and McGraw, 
2004; Kondo et al., 2012). To this end, we performed an antibody-
uptake experiment using a cell line stably expressing FLAG-tagged 
TGN38, as described previously (Ishizaki et al., 2008). Cells treated 
with siRNAs against LacZ (as a control) or against ARF1 and ARF4 
were incubated with anti-FLAG antibody for 50 min at 19.5°C to al-
low accumulation of internalized anti-FLAG together with FLAG-
TGN38, mainly in early endosomes. After an acid wash to remove cell 
surface–bound antibody, internalization was allowed to proceed at 
Tfn and TfnR were observed in prominent tubular structures (Figure 
5A, right, and Supplemental Video S2), and Tfn traveled along 
the tubules. Thus the Tfn-TfnR–positive tubular compartments seem 
to be dynamic structures along which endocytosed Tfn moves 
actively.
Given that ARF1+4 depletion altered the morphology of recy-
cling endosomes, we examined whether this double knockdown af-
fects the endocytic/recycling pathway of Tfn. To this end, we incu-
bated control and double-knockdown cells at 4°C for 50 min with 
Alexa Fluor 488–conjugated Tfn, washed them to remove unbound 
Tfn, and then incubated them at 37°C for various time periods in the 
presence of holo-Tfn to allow internalization of Tfn. Levels of sur-
face-bound Tfn were slightly higher in ARF1+4–depleted cells than 
in control cells (compare Figure 5, B and C, 0 min, and D). Internal-
ization of Tfn was not significantly affected by knockdown of ARF1+4 
(Figure 5, B and C, 5 min). Intracellular Tfn signals were markedly 
decreased after 30-min incubation at 37°C due to release of inter-
nalized Tfn to the extracellular medium in both control and double-
knockdown cells (Figure 5, B and C, 30 min). For an unknown reason, 
the initial signals of surface-bound Tfn were higher in double-knock-
down cells than in control cells. Therefore we plotted ratios of the 
intensity of Tfn signals in the siARF1+4 cells versus the intensity in 
siLacZ-treated cells and found that the ratios were not significantly 
changed at any time point (Figure 5D). These observations are 
FIGURE 3: Redistribution of some proteins in cells depleted of ARF1 and ARF4. HeLa cells were 
treated with siRNAs against LacZ (control; A–E), ARF1 (A′–E′), ARF4 (A′′–E′′), or both ARF1 and 
ARF4 (A′′′–E′′′). Cells were then stained for Rab11 (A–A′′′), TfnR (B–B′′′), CI-MPR (C–C′′′), TGN46 
(D–D′′′), or AP-1 (E–E′′′). The boxed areas in A–C are enlarged in the insets, and those in A′′′, B′′′, 
and C′′′ are enlarged on the right. Bar, 20 μm.
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 of TGN38, although it did induce extensive tubulation of endosomes 
(Kondo et al., 2012), similar to the effect of depleting ARF1+4.
To determine where the internalized FLAG-TGN38 was accumu-
lating in the double-knockdown cells, we compared the trafficking of 
internalized anti-FLAG antibody with that of Alexa Fluor 555–conju-
gated Tfn and Alexa Fluor 488–conjugated EGF, which after endocy-
tosis are transported from early endosomes to recycling endosomes 
and late endosomes, respectively. Endocytosis or lysosomal degrada-
tion of EGF and endocytosis of Tfn were unaffected in cells depleted 
of ARF1+4 (data not shown and Figure 5). In both control and double-
knockdown cells, anti-FLAG was extensively colocalized with both 
internalized Tfn and EGF, mostly in early endosomes, after 0 or 10 min 
at 37°C (Figure 7, A–D, insets). After longer incubations, anti-FLAG in 
control cells was segregated from the Tfn- and EGF-positive endo-
somes and delivered to the TGN (Figure 7, A and B, 30 and 60 min, 
insets). By contrast, in the double-knockdown cells, anti-FLAG was 
extensively colocalized with EGF, although some antibody remained 
partially colocalized with internalized Tfn in tubular structures even 
after longer incubations (Figure 7, C and D, 30 and 60 min, insets). 
These observations suggest that in the double-knockdown cells, 
internalized FLAG-TGN38 was at least partially missorted to EGF-
positive late endosomes instead of being transported to the TGN.
Depletion of ARF1+4 inhibits retrograde transport of MPR 
from endosomes to the TGN
As shown in Figure 3, C–C′′′, knockdown of ARF1+4 results in redis-
tribution of CI-MPR. Therefore we next asked whether the double 
knockdown would affect retrograde transport of MPR from the 
plasma membrane to the TGN via early/recycling endosomes 
(Medigeshi and Schu, 2003; Lin et al., 2004; Saint-Pol et al., 2004). 
To this end, we performed an antibody-uptake experiment using 
cells stably expressing EGFP-tagged cation-dependent MPR 
(CD-MPR). Cells treated with siRNAs against either LacZ or ARF1 
and ARF4 were incubated for 50 min at 19.5°C with anti-GFP anti-
body. After an acid wash, internalization of the antibody was allowed 
to proceed at 37°C for various time periods. In both control and 
double-knockdown cells at 0 min, we observed anti-GFP in periph-
eral punctate structures, colocalized with TfnR (Figure 8, A–D), indi-
cating that internalization of EGFP–CD-MPR was not affected in 
double-knockdown cells. In control cells, anti-GFP was gradually 
transported to the TGN over time: it was colocalized well with gol-
gin-245 after 30 min (Figure 8A), and after 120 min, the majority of 
anti-GFP internalized was colocalized with golgin-245 (Figure 8A) 
and segregated from TfnR (Figure 8B). On the other hand, in cells 
depleted of ARF1+4, we observed anti-GFP in tubular TfnR-positive 
endosomes after 10 min, and some anti-GFP was retained in these 
tubular structures after 120 min (Figure 8D). At this time point, anti-
GFP was also observed in close proximity to the plasma membrane, 
suggesting that EGFP–CD-MPR might be recycled back to the 
plasma membrane rather than transported retrogradely to the TGN. 
Semiquantitative analysis revealed that colocalization of internalized 
anti-GFP was significantly lower in double-knockdown cells than in 
control cells (Figure 8E). Together, these observations indicate that 
ARF1 and ARF4 redundantly regulate the retrograde transport of 
MPR as well as TGN38/46 from recycling endosomes to the TGN. 
We also investigated whether depletion of ARF1+3 inhibits the ret-
rograde transport of EGFP–CD-MPR, but we did not detect any dif-
ference in endosome-to-Golgi transport of EGFP–CD-MPR between 
control and ARF1+3–knockdown cells (Supplemental Figure S6). 
Thus the ARF1+3 and ARF1+4 pairs are both required for recycling 
endosomal integrity, but it is likely that these pairs regulate distinct 
transport pathways from endosomes, with the former regulating the 
37°C for various time periods. In both control and double-knockdown 
cells, anti-FLAG antibody was observed mainly in peripheral punc-
tate structures at 0 min (Figure 6, A and B), indicating that internaliza-
tion of FLAG-TGN38 was not affected in double-knockdown cells. In 
control cells, anti-FLAG was partially colocalized with golgin-97 after 
30 min and extensively colocalized after 60 or 120 min (Figure 6A), 
indicating efficient retrograde transport of FLAG-TGN38 to the TGN. 
In striking contrast, in the double-knockdown cells, the majority of 
internalized anti-FLAG remained in cytoplasmic puncta, with a frac-
tion in tubular structures, even after 60 or 120 min (Figure 6B). Semi-
quantitative analysis of the retrograde transport of FLAG-TGN38 to 
the TGN revealed significant inhibition of transport in double-knock-
down cells (Figure 6C). Depletion of neither ARF1 nor ARF4 alone 
inhibited FLAG-TGN38 transport (data not shown). These results in-
dicate that ARF1 and ARF4 redundantly regulate the retrograde 
transport of TGN38/46 from endosomes to the TGN. As we reported 
previously, depletion of ARF1+3 did not affect retrograde transport 
FIGURE 4: Rab4- and Rab11-positive, but not Rab5-positive, 
endosomes are tubulated in cells depleted of ARF1 and ARF4. HeLa 
cells treated with siRNAs against LacZ (A) or ARF1 and ARF4 (B) were 
transfected with expression plasmids encoding EGFP-Rab5, EGFP-
Rab4, or EGFP-Rab11 and then immunostained for TfnR. Bar, 20 μm.
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for Rab11 and Rab4 but not for Rab5. The tubular structures induced 
by ARF1+4 depletion did not include early endosomes (Figure 4 and 
Supplemental Figure S3C) or late endosomes (Figure 7). Moreover, we 
found that ARF1 and ARF4 are required for the retrograde transport of 
TGN38/46 and MPR from recycling endosomes to the TGN but not 
that of CD4-furin from late endosomes to the TGN or for endocytosis 
of TGN38, MPR, Tfn, or EGF from the plasma membrane.
Previous studies showed that exogenously expressed ARF1 and 
ARF4 are mainly localized to the ERGIC and the Golgi (Kawamoto 
et al., 2002; Chun et al., 2008; Ben-Tekaya et al., 2010), and their 
depletion induces formation of tubules from the ERGIC (Ben-Tekaya 
et al., 2010; Supplemental Figure S2). Although class I and II ARFs 
localize mainly to the Golgi apparatus, ARF proteins have been pro-
posed to serve various functions at other cellular compartments. 
Some examples follow: 1) Class I ARFs localize to recycling endo-
somes and regulate the Tfn recycling pathway (Kondo et al., 2012); 
BIG2, which is an ARF-GEF for ARF1 and ARF3, localizes to recycling 
endosomes (Shin et al., 2004). 2) ARF1 can be activated at the 
plasma membrane, where it regulates dynamin-independent endo-
cytosis (Cohen et al., 2007; Kumari and Mayor, 2008). 3) Class II 
ARFs and ARF6 share effector proteins, the arfophilins/Rab11-FIPs, 
with Rab11 (Shin et al., 1999; Meyers and Prekeris, 2002; Shiba 
et al., 2006), although a functional cross-talk between class II ARFs 
and Rab11 is not clear. 4) ARF5 is activated by BRAGs, a subfamily 
of ARF-GEFs, and mediates integrin internalization (Moravec et al., 
2012). 5) ARF4 plays an important role in formation of the post-TGN 
recycling pathway to the plasma membrane and the latter regulat-
ing the retrograde transport pathway to the TGN.
Depletion of ARF1+4 does not inhibit retrograde transport 
of CD4-furin through late endosomes
Next we examined whether ARF1 and ARF4 are involved in another 
retrograde pathway, from late endosomes to the TGN. To this end, 
we used a cell line stably expressing a CD4-furin chimera (Mallet and 
Maxfield, 1999; Maxfield and McGraw, 2004; Schapiro et al., 2004; 
Ishizaki et al., 2008) and analyzed retrograde transport of CD4-furin 
by following extracellularly applied anti-CD4 antibody. Cells treated 
with siRNAs against either LacZ or ARF1 and ARF4 were incubated 
for 50 min at 4°C with anti-CD4 antibody. After washing with phos-
phate-buffered saline (PBS), internalization was allowed to proceed 
at 37°C for the indicated time periods (Figure 9). Immunofluores-
cence and subsequent semiquantitative analysis did not reveal any 
significant differences between control and double-knockdown cells 
over the course of incubation (Figure 9, A–C). After 120 min, the 
majority of CD4-furin reached golgin-97–positive Golgi structures 
(Figure 9C) in both control and double-knockdown cells. Therefore 
it is likely that the ARF1+4 pair does not participate in the retrograde 
transport of CD4-furin from late endosomes to the TGN.
DISCUSSION
We showed that ARF1 and ARF4 play redundant roles in maintaining 
the integrity of recycling endosomal compartments, which are positive 
FIGURE 5: Depletion of ARF1 and ARF4 does not affect the endocytic/recycling pathway of Tfn. (A) HeLa cells stably 
expressing TfnR-EGFP were transfected with siRNAs against LacZ or ARF1 and ARF4, incubated at 37°C for 30 min with 
Alexa Fluor 555–conjugated Tfn, and then subjected to time-lapse recording. Representative frames from Supplemental 
Videos S1 and S2 are shown. (B, C) HeLa cells treated with siRNAs against LacZ (B) or both ARF1 and ARF4 (C) were 
serum starved for 3 h and then incubated at 4°C for 50 min with Alexa Fluor 555–conjugated Tfn at 37°C for the 
indicated times. Bars, 20 μm. (D) Pixel intensity of Alexa Fluor 555–Tfn estimated at the indicated times. Data are shown 
as the ratio of the mean of cellular Tfn intensities between cells depleted of ARF1+4 and controls at each time point. 
The graph is representative of three independent experiments, and >50 cells were analyzed.
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 distinct membrane microdomains: on one 
hand, ARF1 regulates, redundantly with 
ARF4, retrograde transport from recycling 
endosomes to the TGN; on the other hand, 
redundantly with ARF3, it regulates recy-
cling to the plasma membrane.
How do ARF1 and ARF4 regulate retro-
grade transport from endosomes? It is pos-
sible that the ARF1+ARF4 pair is a primary 
regulator of recruitment of the AP-1 adaptor 
complex to TGN and endosomal mem-
branes (Figure 3E′′′). Because AP-1 is re-
quired for endosome-to-TGN transport of 
MPR (Meyer et al., 2000), ARF1 and ARF4 
may be involved in retrograde transport 
through recruitment of the AP-1 complex. 
The defect in MPR retrograde transport in-
duced by knockdown of ARF1+4, however, 
was not phenocopied by knockdown of 
AP-1 (Seaman, 2007; data not shown). Thus 
a direct functional link between AP-1 and 
ARF1+ARF4 in retrograde trafficking remains 
to be elucidated. Because depletion of 
ARF1+4 dissociates COPI from the Golgi 
(Volpicelli-Daley et al., 2005), we asked 
whether knockdown of COPI as well as that 
of GBF1 phenocopied that of ARF1+4. Both 
knockdowns, however, failed to induce tu-
bulation of TfnR-positive endosomes (Guo 
et al., 2008; Saitoh et al., 2009; Supplemen-
tal Figure S7). Retromer is also required for 
the retrograde transport of MPR and TGN38 
(Seaman, 2004; Lieu and Gleeson, 2010). 
We examined whether ARF1+4 knockdown 
affected the localization of Vps35, a compo-
nent of the retromer complex, but did not 
find any changes relative to control cells 
(Supplemental Figure S2), suggesting that 
the ARF1+4 pair does not participate in re-
cruitment of the retromer complex. EpsinR, 
which interacts with AP-1 and clathrin, is required for retrograde 
transport of TGN46 and CI-MPR (Hirst et al., 2003; Saint-Pol et al., 
2004). In addition, brefeldin A causes redistribution of epsinR from 
membranes into the cytosol, suggesting that epsinR membrane as-
sociation requires ARF proteins (Hirst et al., 2003). Thus epsinR is an-
other candidate downstream effector of ARF1 and ARF4.
It remains important to determine how distinct combinations of 
ARFs sort cargoes targeted to distinct organelles and regulate sepa-
rate transport processes on the same compartments. ARFs may act 
within distinct membrane microdomains along with distinct effector 
proteins. Therefore identification of specific downstream effectors 
for ARF1+ARF4 and ARF1+ARF3 may allow us to understand the 
mechanisms underlying the regulation of the intricate processes of 
trafficking from recycling endosomes.
MATERIALS AND METHODS
Plasmids
An expression vector for C-terminally EGFP-tagged ARF4 was 
constructed by subcloning the entire coding sequence of human 
ARF4 into the pCAG vector. Construction of expression vectors 
for C-terminally HA- or EGFP-tagged ARFs was described previ-
ously (Takatsu et al., 2002; Kondo et al., 2012; Makyio et al., 2012). 
carriers targeted to primary cilia (Mazelova et al., 2009) and has 
been identified in primary cilia by proteomic analysis (Ishikawa et al., 
2012). Here we extended the known repertoire of ARFs in other cel-
lular compartments by elucidating a redundant function of ARF1 
and ARF4 in endosome-to-Golgi transport.
Tubulation of recycling endosomes is not induced by depletion 
of ARF1, ARF3, or ARF4 alone but is induced by pairwise depletion 
of ARF1+4 or ARF1+3. However, the tubules induced by depletion 
of ARF1+4 appear to be more extensive than those induced by 
depletion of ARF1+3 (Figure 1) and cannot be rescued by exoge-
nous expression of ARF3 (Figure 2). These observations indicate 
that depletion of ARF1+4 and that of ARF1+3 induce tubules from 
recycling endosomes by distinct mechanisms. Intriguingly, ARF1+4 
and ARF1+3 knockdowns affect distinct transport pathways from 
recycling endosomes: ARF1+4 depletion inhibits the retrograde 
transport of TGN38 and MPR to the TGN (Figures 6 and 8) but not 
Tfn recycling (Volpicelli-Daley et al., 2005; Figure 5), whereas 
ARF1+3 depletion inhibits the Tfn recycling pathway but not the 
retrograde pathway from recycling endosomes (Kondo et al., 2012; 
Supplemental Figure S4). On the basis of these results, we conclude 
that the ARF1+4 and ARF1+3 pairs participate in distinct transport 
pathways from recycling endosomes, probably by functioning in 
FIGURE 6: ARF1 and ARF4 are required for retrograde transport of FLAG-TGN38 from 
endosomes to the Golgi complex. Cells stably expressing FLAG-TGN38 were treated with 
siRNAs against LacZ (A) or both ARF1 and ARF4 (B). Cells were incubated at 19.5°C for 50 min 
with anti-FLAG antibodies to allow the antibody to accumulate in early endosomes (0 min) and 
then chased at 37°C for indicated times. Cells were then immunostained for FLAG and 
golgin-97. Arrows indicate tubular structures. Bars, 20 μm. (C) Golgi arrival of internalized 
FLAG-TGN38 was estimated by counting cells in which FLAG-TGN38 was colocalized with 
golgin-97. Gray bars indicate cells in which internalized FLAG-TGN38 was observed in a distinct 
ribbon-like structure that extensively colocalized with golgin-97; examples are marked with 
asterisks. Black bars indicate cells in which internalized FLAG-TGN38 was not colocalized with 
golgin-97. Results are means ± SD from two independent experiments.
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Antibodies and reagents
Sources of antibodies used in this study were as follows: polyclonal 
rabbit anti-GBF1 was prepared as described previously (Kawamoto 
et al., 2002); polyclonal rabbit anti-TGN46 (Kain et al., 1998) was a 
kind gift from Minoru Fukuda (Sanford-Burnham Medical Research 
Construction of expression vectors for N-terminally EGFP-tagged 
Rab11a and Rab4 was described previously (Yamamoto et al., 
2010; Takahashi et al., 2011). The EGFP-Rab5 construct was kindly 
provided by Marino Zerial (Max Planck Institute, Dresden, 
Germany).
FIGURE 7: Internalized FLAG-TGN38 is retained in endosomal structures in cells depleted of ARF1 and ARF4. Cells 
stably expressing FLAG-TGN38 were treated with siRNAs against LacZ (A, B) or both ARF1 and ARF4 (C, D). The cells 
were incubated with anti-FLAG antibody as described in Figure 6 in the presence of Alexa Fluor 555–conjugated Tfn 
(A, C) or Alexa Fluor 488–conjugated EGF (B, D) for the indicated time periods. Cells were then immunostained for 
FLAG. Bars, 20 μm.
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 University, Tsukuba, Japan); polyclonal rab-
bit anti-ARF4 was from Protein Tech 
(Chicago, IL); polyclonal rabbit anti-GFP was 
from Molecular Probes (Eugene, OR); mono-
clonal mouse antibodies against GM130, 
golgin-245, EEA1, CD4, Rab11, ARF3, and 
GFP (JL-8, for immunoblotting) were from 
BD Biosciences (San Diego, CA); monoclo-
nal mouse antibodies against γ-adaptin 
(100.3) and FLAG (M2) were from Sigma-
Aldrich (St. Louis, MO); monoclonal mouse 
anti-CI-MPR was from Thermo Scientific 
(Waltham, MA); monoclonal mouse anti-
TfnR was from Invitrogen (Carlsbad, CA); 
monoclonal mouse anti-ERGIC53 was from 
Alexis (San Diego, CA); monoclonal mouse 
anti-ARF1 was from Enzo Life Sciences 
(Plymouth Meeting, PA); monoclonal mouse 
anti-ARF5 was from Abnova (Taipei City, 
Taiwan); monoclonal mouse anti-ARF6 was 
from Santa Cruz Biotechnology (Santa Cruz, 
CA); monoclonal mouse anti–β-actin and 
anti–β-tubulin were from Millipore (Billerica, 
MA); monoclonal rat anti-HA was from Roche 
Applied Sciences (Indianapolis, IN); poly-
clonal goat anti-VPS35 was from Imgenex 
(San Diego, CA); Alexa Fluor–conjugated 
secondary antibodies were from Molecular 
Probes; and horseradish peroxidase–
conjugated secondary antibodies were from 
Jackson ImmunoResearch Laboratories 
(West Grove, PA). Alexa Fluor–conjugated 
Tfn and EGF were purchased from Molecular 
Probes.
Cell culture, RNA interference, 
immunofluorescence, and time-lapse 
imaging analysis
Culture of HeLa cells and transfection of 
expression plasmids were performed as 
described previously (Shin et al., 2004, 
2005). HeLa cell lines stably expressing 
FLAG-TGN38, CD4-furin, and TfnR-EGFP 
were established as described previously 
(Ishizaki et al., 2008; Takahashi et al., 2012). 
A HeLa cell line stably expressing EGFP-
CD-MPR was established by transfection of 
HeLa cells with pCIpreEGFP-CDMPR, 
which was constructed by replacing the CI-
MPR portion of pCIpreEGFP-CIMPRtail 
(Waguri et al., 2003) with the coding se-
quence of mature rat CD-MPR and subse-
quent selection in the presence of G418 
sulfate. Knockdowns of ARFs, β-COP, or 
GBF1 were performed as described previ-
ously (Ishizaki et al., 2006, 2008; Saitoh 
et al., 2009; Takashima et al., 2011; Kondo 
et al., 2012). Briefly, pools of siRNAs tar-
geted against the 3′-untranslated region of human ARF1 or ARF3, 
as described previously (Kondo et al., 2012), ARF4 (PCR amplified 
using the primer pair 5′-TAAAGAAATTCTCCTTGGGAAAAAA-3′ 
and 5′-TAACAAAAGCAACATGCAACATAA-3′), or the partial 
Institute, La Jolla, CA); polyclonal rabbit anti-golgin-97 (Yoshimura 
et al., 2004) was a kind gift from Nobuhiro Nakamura (Kyoto 
Sangyo University, Kyoto, Japan); polyclonal rabbit anti-ARF6 
(Honda et al., 1999) was a kind gift from Yasunori Kanaho (Tsukuba 
FIGURE 8: ARF1 and ARF4 are required for retrograde transport of EGFP-CD-MPR from 
endosomes to the Golgi complex. Cells stably expressing EGFP-CD-MPR were treated with 
siRNAs against LacZ (A, B) or both ARF1 and ARF4 (C, D). Cells were incubated at 19.5°C for 
50 min with anti-GFP antibody to allow the antibody to accumulate in early endosomes and then 
chased at 37°C for indicated time periods. The cells were then immunostained for GFP and either 
golgin-245 (A, C) or TfnR (B, D). Images were acquired using an A1R-MP confocal microscope. 
Bars, 20 μm. (E) Colocalization of internalized EGFP-CD-MPR with golgin-245 was quantified 
using MetaMorph software. The graph is representative of three independent experiments.
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placed on a microscope stage prewarmed 
to 37°C, and then observed using an A1R-
MP confocal microscope (Nikon, Melville, 
NY). Images were acquired sequentially 
every 2 s.
Tfn and antibody-uptake experiments
Assay for internalization and recycling of 
Tfn was carried out according to previ-
ously described protocols (Shin et al., 
2004). HeLa cells were transfected with a 
pool of siRNAs against either LacZ (as a 
control) or ARFs as described. At 72 or 
120 h posttransfection, cells were serum 
starved for 3 h in MEM containing 0.2% 
bovine serum albumin and then incubated 
on ice for 50 min with Alexa Fluor 555– 
conjugated Tfn. After washing out of fluo-
rescent Tfn with PBS on ice, cells were 
incubated in medium containing unlabeled 
holo-Tfn at 37°C for the indicated times 
and then processed for immunofluores-
cence analysis. Immunofluorescence anal-
ysis was performed using an Axiovert 
200 MAT microscope (Carl Zeiss, Jena, 
Germany) for epifluorescence images or 
an A1R-MP confocal microscope for con-
focal images. The intensity of fluorescent 
Tfn was quantitated using the MetaMorph 
imaging software (Molecular Devices, 
Sunnyvale, CA).
Uptake of anti-GFP, anti-FLAG, or anti-
CD4 antibody in cells stably expressing 
EGFP-CD-MPR, FLAG-TGN38, or CD4-
furin, respectively, was assayed as de-
scribed previously (Takahashi et al., 1995; 
Shin et al., 2004, 2005; Ishizaki et al., 
2008) with some modifications. Briefly, 
HeLa cells stably expressing EGFP-CD-
MPR, FLAG-TGN38, or CD4-furin were 
mock treated with a pool of siRNAs against LacZ or a control 
siRNA pool (Dharmacon) or treated with a pool of siRNAs against 
ARFs or siGENOME SMARTpool against ARF4. Cells expressing 
FLAG-TGN38 and CD4-furin were incubated with 15 mM sodium 
butyrate for 16 h before antibody uptake. The cells were then in-
cubated for 60 min with polyclonal anti-GFP or monoclonal anti-
FLAG (M2) antibody at 19.5°C or monoclonal anti-CD4 (Leu3a) at 
4°C, as appropriate; subjected to an acid wash (0.5% acetic acid, 
pH 3.0, 50 mM NaCl) in the anti-GFP and anti-FLAG uptake as-
say; and finally incubated at 37°C for the indicated periods of 
time. Colocalization of internalized anti-GFP with golgin-245 in 
the EGFP-CD-MPR–expressing cells was quantified using Meta-
Morph imaging software.
coding and 3′-untranslated regions of human ARF5 (PCR amplified 
using the primer pair 5′-ACCTCTGCCACCCAAGGCAC-3′ and 
5′-CAAACCACAGCAAA TTTATTACTC-3′) were prepared using a 
BLOCK-iT RNAi TOPO transcription kit and a BLOCK-iT Dicer RNAi 
kit (Invitrogen). For siARF4′, siGENOME SMARTpool (Dharmacon, 
Lafayette, CO) was purchased. Cells were transfected with the 
siRNAs using Lipofectamine 2000 (Invitrogen) and incubated for 
24 h. The transfected cells were then split and seeded onto culture 
dishes. After 24 h, the cells were transfected again with the siRNAs 
and incubated for 48 h. The transfected cells were then transferred 
to new culture dishes containing coverslips, incubated for another 
24 h, and processed for immunofluorescence and immunoblot 
analyses as described previously (Shin et al., 1997; Ishizaki et al., 
2008; Nishimoto-Morita et al., 2009; Takahashi et al., 2012). In the 
case of simultaneous knockdown of ARF1 and ARF4, cells were 
directly seeded onto coverslips or culture dishes and incubated for 
24 h. The cells were transfected with siRNAs using Lipofectamine 
2000, incubated for another 48 h, and processed for immunofluo-
rescence and immunoblot analyses. For time-lapse recording, the 
TfnR-EGFP expressing cells (Kondo et al., 2012; Takatsu et al., 
2013) were treated with siRNAs as described, incubated in 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid–buffered MEM, 
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FIGURE 9: ARF1 and ARF4 are not required for retrograde transport of CD4-furin from 
endosomes to the Golgi complex. Cells stably expressing CD4-furin were treated with siRNAs 
against LacZ (A) or both ARF1 and ARF4 (B). Cells were then incubated at 4°C for 60 min with 
anti-CD4 antibodies to allow the antibody to bind cell surface (A, B; 0 min) and then chased at 
37°C for indicated times. Cells were immunostained for CD4 and golgin-97. Bars, 20 μm. 
(C) Golgi arrival of internalized CD4-furin was estimated as described in Figure 6. Gray bars 
indicate cells in which internalized CD4-furin was observed in a distinct ribbon-like structure that 
extensively colocalized with golgin-97; examples are marked with asterisks. Black bars indicate 
cells in which the internalized CD4-furin was not colocalized with golgin-97. Results are means ± 
SD from two independent experiments.
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